Breaking News Instant updates and real-time market news.

MYL

Mylan

$36.68

-0.17 (-0.46%)

, BMY

Bristol-Myers

$56.98

0.23 (0.41%)

07:31
11/28/16
11/28
07:31
11/28/16
07:31

Mylan signs sub-license agreement with Medicines Patent Pool

Mylan (MYL) announced that the company has signed an agreement with the Medicines Patent Pool to expand access to chronic hepatitis C medicines in developing countries. The agreement licenses Mylan to produce and market a generic version of Bristol-Myers Squibb's (BMY) DAKLINZA Tablets, 30 mg and 60 mg, for distribution in 112 low and middle income countries. Daclatasvir Tablets, 30 mg and 60 mg, are indicated for use with sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus genotype 1 or genotype 3 infection in the U.S. and genotype 1, 3 and 4 in Europe. The license allows Mylan to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of HCV. Earlier this year, the World Health Organization added several new hepatitis C treatments, including daclatasvir, to its essential medicines list, highlighting the urgent need to promote equitable access to innovative medicines.

MYL

Mylan

$36.68

-0.17 (-0.46%)

BMY

Bristol-Myers

$56.98

0.23 (0.41%)

  • 03

    Dec

  • 28

    Mar

MYL Mylan
$36.68

-0.17 (-0.46%)

10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.
10/10/16
10/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Strong Buy from Market Perform at Raymond James with Elliot WIlbur saying the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. 2. Under Armour (UA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Tom Nikic saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales re-acceleration over the next 12-18 months. 3. Deere (DE) and AGCO (AGCO) were upgraded to Outperform from Market Perform at Wells Fargo. 4. Dow Chemical (DOW) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." 5. Exelixis (EXEL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying the data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/25/16
MZHO
10/25/16
INITIATION
Target $49
MZHO
Buy
Mylan initiated with a Buy at Mizuho
Mizuho analyst Irina Koffler initiated Mylan with a Buy and a $49 price target.
10/26/16
10/26/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL) initiated with a Buy at Mizuho. 2. Five Below (FIVE) initiated with a Buy at Longbow. 3. NetSuite (N) reinstated with an Underperform at BofA/Merrill. 4. Adient (ADNT) initiated with a Buy at Northcoast. 5. Party City (PRTY) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
BMY Bristol-Myers
$56.98

0.23 (0.41%)

10/28/16
HDLY
10/28/16
UPGRADE
HDLY
Long-Term Buy
Bristol-Myers upgraded to Long-Term Buy from Neutral at Hilliard Lyons
10/28/16
10/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Perform from Underperform at Oppenheimer with analyst Jason Helfstein saying the stock's valuation now "properly" reflects the challenging fundamental outlook. 2. Bristol-Myers (BMY) upgraded to Long-Term Buy from Neutral at Hilliard Lyons. 3. Qualcomm (QCOM) upgraded on valuation at BMO Capital with analyst Tim Long saying he is neutral on Qualcomm's acquisition of NXP (NXPI), but he expects Qualcomm's stock to stay in a trading range in the wake of the deal. 4. Level 3 (LVTL) upgraded to Outperform from Perform at Oppenheimer with analyst Timothy Horan saying the company has restructured itself in the last few years and now has operational/financial flexibility on free cash flow, with the analyst seeing accelerating growth in 2017. 5. ConocoPhillips (COP) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company reported "another solid quarter." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/03/16
JPMS
11/03/16
NO CHANGE
JPMS
JPMorgan calls Lilly, Bristol-Myers, Allergan favorite pharma majors
Following a "challenging" Q3 earnings season for the major pharmaceuticals companies, JPMorgan analyst Chris Schott said pricing continues to be a major overhang on the space. However, he believes these and other challenges are "increasingly well reflected" in both earnings and sector multiples and recommends companies early in new product launch cycles. Coming out of the earnings season, Schott named Eli Lilly (LLY), Bristol-Myers (BMY) and Allergan (AGN) as his favorite names in the large-cap pharma space.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.

TODAY'S FREE FLY STORIES

RAD

Rite Aid

$3.93

0.19 (5.08%)

, WBA

Walgreens Boots Alliance

$77.09

-0.17 (-0.22%)

20:25
06/28/17
06/28
20:25
06/28/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

RAD

Rite Aid

$3.93

0.19 (5.08%)

WBA

Walgreens Boots Alliance

$77.09

-0.17 (-0.22%)

MKC

McCormick

$98.95

0.42 (0.43%)

LNN

Lindsay

$88.04

1.44 (1.66%)

GBX

Greenbrier

$50.00

0.55 (1.11%)

CAG

Conagra Brands

$37.37

0.37 (1.00%)

STZ

Constellation Brands

$183.68

1.4 (0.77%)

AYI

Acuity Brands

$179.73

4.4 (2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 07

    Jul

FUL

H.B. Fuller

$53.67

1.59 (3.05%)

19:53
06/28/17
06/28
19:53
06/28/17
19:53
Earnings
H.B. Fuller narrows FY17 adjusted EPS to $2.57-$2.67 from $2.57-$2.77 »

EPS consensus $2.66.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FUL

H.B. Fuller

$53.67

1.59 (3.05%)

19:51
06/28/17
06/28
19:51
06/28/17
19:51
Earnings
H.B. Fuller reports Q2 adjusted EPS 62c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

NERV

Minerva

$7.95

-0.65 (-7.56%)

19:46
06/28/17
06/28
19:46
06/28/17
19:46
Syndicate
Minerva 5M share Secondary priced at $7.75 »

Citi and Jefferies acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

GOV

Government Properties

$19.33

-2.565 (-11.72%)

19:45
06/28/17
06/28
19:45
06/28/17
19:45
Syndicate
Government Properties 25M share Secondary priced at $18.50 »

Citi, BofA/Merrill,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

APRN

Blue Apron

19:41
06/28/17
06/28
19:41
06/28/17
19:41
Syndicate
Blue Apron 30M share IPO priced at $10.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SO

Southern Company

$49.15

-0.25 (-0.51%)

, TOSBF

Toshiba, also use TOSYY

$2.57

-0.03 (-1.15%)

19:29
06/28/17
06/28
19:29
06/28/17
19:29
Hot Stocks
Georgia Power, Southern Nuclear to assume Vogtle project management by late July »

Georgia Power (SO) and…

SO

Southern Company

$49.15

-0.25 (-0.51%)

TOSBF

Toshiba, also use TOSYY

$2.57

-0.03 (-1.15%)

TOSYY

Toshiba, also use TOSBF

$15.28

-0.39 (-2.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$199.62

0.73 (0.37%)

, BDRBF

Bombardier

$1.87

0.039 (2.13%)

19:29
06/28/17
06/28
19:29
06/28/17
19:29
Periodicals
Boeing requests delay in ruling on Bombardier complaint, Reuters says »

Boeing (BA) has requested…

BA

Boeing

$199.62

0.73 (0.37%)

BDRBF

Bombardier

$1.87

0.039 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BAC

Bank of America

$23.88

0.61 (2.62%)

, BRK.A

Berkshire Hathaway

$254,660.00

3350 (1.33%)

19:22
06/28/17
06/28
19:22
06/28/17
19:22
Periodicals
Berkshire may swap Bank of America preferred shares after CCAR news, WSJ says »

After Bank of America…

BAC

Bank of America

$23.88

0.61 (2.62%)

BRK.A

Berkshire Hathaway

$254,660.00

3350 (1.33%)

BRK.B

Berkshire Hathaway

$169.89

2.54 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WATT

Energous

$15.39

0.16 (1.05%)

, DLGNF

Dialog Semiconductor

19:01
06/28/17
06/28
19:01
06/28/17
19:01
Hot Stocks
Dialog invests extra $15M in Energous »

Energous (WATT) announced…

WATT

Energous

$15.39

0.16 (1.05%)

DLGNF

Dialog Semiconductor

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$187.92

0.51 (0.27%)

18:59
06/28/17
06/28
18:59
06/28/17
18:59
Periodicals
Anthem to curtail plan offerings in most of Nevada, WSJ reports »

Anthem plans to stop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSN

VeriSign

$93.77

0.97 (1.05%)

18:36
06/28/17
06/28
18:36
06/28/17
18:36
Hot Stocks
VeriSign says renews .net control through 2023 »

VeriSign disclosed in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DD

DuPont

$81.28

0.59 (0.73%)

, DOW

Dow Chemical

$63.25

0.62 (0.99%)

18:34
06/28/17
06/28
18:34
06/28/17
18:34
Hot Stocks
DuPont, Dow Chemical boards reiterate support of merger agreement »

Dow Chemical Company…

DD

DuPont

$81.28

0.59 (0.73%)

DOW

Dow Chemical

$63.25

0.62 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TPX

Tempur Sealy

$50.87

0.07 (0.14%)

18:33
06/28/17
06/28
18:33
06/28/17
18:33
Hot Stocks
Tempur Sealy enters standstill pact with H Partners, board member Nabi »

Tempur Sealy disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALJ

Alon USA Energy

$13.33

0.15 (1.14%)

, DK

Delek US

$26.43

0.25 (0.95%)

18:26
06/28/17
06/28
18:26
06/28/17
18:26
Hot Stocks
Alon USA Energy stockholders approve Delek US merger »

Alon USA Energy (ALJ)…

ALJ

Alon USA Energy

$13.33

0.15 (1.14%)

DK

Delek US

$26.43

0.25 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

ANCUF

Alimentation Couche-Tard

$49.30

0.144 (0.29%)

, CST

CST Brands

18:25
06/28/17
06/28
18:25
06/28/17
18:25
Hot Stocks
Alimentation Couche-Tard confirms closing of CST Brands acquisition »

Alimentation Couche-Tard…

ANCUF

Alimentation Couche-Tard

$49.30

0.144 (0.29%)

CST

CST Brands

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$50.60

0.92 (1.85%)

18:04
06/28/17
06/28
18:04
06/28/17
18:04
Hot Stocks
BNY Mellon announces strategic alliance with One Investment Group »

BNY Mellon and One…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

PRGS

Progress Software

$30.82

0.74 (2.46%)

, WOR

Worthington

$47.36

2 (4.41%)

18:03
06/28/17
06/28
18:03
06/28/17
18:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

PRGS

Progress Software

$30.82

0.74 (2.46%)

WOR

Worthington

$47.36

2 (4.41%)

GEMP

Gemphire Therapeutics

$12.27

0.43 (3.63%)

NXTD

Nxt-ID

$1.66

0.2505 (17.77%)

KLIC

Kulicke & Soffa

$20.02

0.53 (2.72%)

SRPT

Sarepta

$33.86

0.83 (2.51%)

SPLS

Staples

$9.93

0.77 (8.41%)

FITB

Fifth Third

$25.49

0.4 (1.59%)

DFS

Discover

$61.88

0.81 (1.33%)

STI

SunTrust

$56.09

0.88 (1.59%)

C

Citi

$65.18

0.95 (1.48%)

RF

Regions Financial

$14.09

0.09 (0.64%)

BK

BNY Mellon

$50.60

0.92 (1.85%)

JPM

JPMorgan

$89.82

1.77 (2.01%)

CFG

Citizens Financial

$35.34

0.5 (1.44%)

BAC

Bank of America

$23.88

0.61 (2.62%)

MS

Morgan Stanley

$44.32

0.1 (0.23%)

WFC

Wells Fargo

$54.33

1.17 (2.20%)

PNC

PNC Financial

$123.40

2.28 (1.88%)

ZION

Zions Bancorp

$42.97

0.43 (1.01%)

GS

Goldman Sachs

$223.22

2.94 (1.33%)

AXP

American Express

$83.97

0.89 (1.07%)

USB

U.S. Bancorp

$51.98

0.84 (1.64%)

PIR

Pier 1 Imports

$5.38

0.04 (0.75%)

BLCM

Bellicum Pharmaceuticals

$13.32

0.18 (1.37%)

AKBA

Akebia

$15.50

-0.19 (-1.21%)

DOC

Physicians Realty Trust

$21.60

0.08 (0.37%)

CRZO

Carrizo Oil & Gas

$15.61

-0.47 (-2.92%)

COF

Capital One

$82.98

1.6 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 14

    Jul

  • 14

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 21

    Jul

  • 21

    Jul

  • 21

    Jul

  • 21

    Jul

  • 25

    Jul

  • 26

    Jul

  • 03

    Aug

  • 26

    Sep

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 30

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

VRX

Valeant

$17.15

0.5 (3.00%)

18:02
06/28/17
06/28
18:02
06/28/17
18:02
Hot Stocks
Salix confirms FDA accepts NDA for PLENVU »

Valeant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

NTNX

Nutanix

$20.36

1.72 (9.23%)

, GOOG

Alphabet

$940.49

13.16 (1.42%)

18:02
06/28/17
06/28
18:02
06/28/17
18:02
Hot Stocks
Nutanix announces strategic alliance with Google Cloud »

Nutanix (NTNX) announced…

NTNX

Nutanix

$20.36

1.72 (9.23%)

GOOG

Alphabet

$940.49

13.16 (1.42%)

GOOGL

Alphabet Class A

$961.01

12.92 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

CE

Celanese

$93.42

0.62 (0.67%)

18:02
06/28/17
06/28
18:02
06/28/17
18:02
Hot Stocks
Celanese increases price of Dibutyl Maleate and Dioctyl Maleate in Europe »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$223.22

2.94 (1.33%)

18:00
06/28/17
06/28
18:00
06/28/17
18:00
Hot Stocks
Goldman Sachs: Fed did not object to capital plan »

Goldman Sachs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 17

    Oct

COLB

Columbia Banking

$39.35

0.49 (1.26%)

17:56
06/28/17
06/28
17:56
06/28/17
17:56
Hot Stocks
Columbia Banking names Hadley Robbins CEO »

Columbia Banking System…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFBK

Northfield Bancorp

$17.36

0.3 (1.76%)

17:55
06/28/17
06/28
17:55
06/28/17
17:55
Hot Stocks
Northfield Bancorp CEO John Alexander to retire, Steven Klein to succeed »

Northfield Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$22.96

0.25 (1.10%)

, AAL

American Airlines

$49.25

0.75 (1.55%)

17:43
06/28/17
06/28
17:43
06/28/17
17:43
Hot Stocks
Homeland Security announces new aviation security measures »

Secretary of Homeland…

JBLU

JetBlue

$22.96

0.25 (1.10%)

AAL

American Airlines

$49.25

0.75 (1.55%)

UAL

United Continental

$76.70

0.7 (0.92%)

DAL

Delta Air Lines

$53.84

1 (1.89%)

LUV

Southwest

$62.01

0.5 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 07

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.